Wednesday was a historic day in the biotech field. A revolutionary way of fighting cancer was approved for the first time by the Food and Drug Administration. Novartis’ (NYSE: NVS) CAR-T therapy Kymriah got the green light from U.S. regulators
September 4, 2017
RBOB Gasoline futures tumbled to their lowest level in almost a week overnnight as several US Gulf Coast refineries reported their plans to restart operations after the devastation of Hurricane Harvey forced them to shutdown. While about one-fifth of U.S. refining capacity is halted, according to data